COVID-19 plasma proteome reveals novel temporal and cell-specific signatures for disease severity and high-precision disease managementArticle Published on 2023-01-012023-07-11 Journal: Journal of Cellular and Molecular Medicine [Category] COVID19(2023년), [키워드] COVID-19 disease severity precision medicine proteome. [DOI] 10.1111/jcmm.17622 PMC 바로가기
Clinical severity according to the primary infection variant in patients with suspected SARS-CoV-2 reinfection in KoreaArticle Published on 2023-01-012023-07-11 Journal: Epidemiology and Health [Category] COVID19(2023년), [키워드] COVID-19 disease severity omicron Reinfection vaccination. [DOI] 10.4178/epih.e2023007 PMC 바로가기
Significance of Catecholamine Biosynthetic/Metabolic Pathway in SARS-CoV-2 Infection and COVID-19 SeverityArticle Published on 2022-12-202023-07-11 Journal: Cells [Category] COVID19(2023년), [키워드] catecholamine pathway disease severity dopamine. L-Dopa decarboxylase SARS-CoV-2 [DOI] 10.3390/cells12010012 PMC 바로가기
Impact of Vaccination and Early Monoclonal Antibody Therapy on Coronavirus Disease 2019 Outcomes in Organ Transplant Recipients During the Omicron WaveArticle Published on 2022-12-192023-07-08 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), [키워드] disease severity Immunosuppression mRNA vaccine SARS-CoV-2 Sotrovimab. [DOI] 10.1093/cid/ciac324 PMC 바로가기
Clinical characteristics and outcome of Covid-19 illness and predictors of in-hospital mortality in Saudi ArabiaArticle Published on 2022-12-172023-07-11 Journal: BMC Infectious Diseases [Category] COVID19(2023년), [키워드] AUC case fatality Comorbidities disease severity Hospitalization ICU-admission Key parameters laboratory findings Risk factors SARS-CoV-2. [DOI] 10.1186/s12879-022-07945-8 PMC 바로가기
Impaired immune response drives age-dependent severity of COVID-19Article Published on 2022-12-052022-11-15 Journal: The Journal of Experimental Medicine [Category] COVID19(2023년), SARS, 치료제, [키워드] Adaptive immune response Aggravated Antiviral benefit caused characterized combinatorial treatment correlation COVID-19 disease disease severity function IFN IFN-γ IFN-λ immune response Immunity Immunotherapy Impaired increasing age individual interferon mice reversed SARS-COV-2 infection severe COVID-19 severe disease severity of COVID-19 susceptibility Therapeutic treatment type I virus replication [DOI] 10.1084/jem.20220621 PMC 바로가기
Viral infectious diseases severity: co-presence of transcriptionally active microbes (TAMs) can play an integral role for disease severityReview Published on 2022-12-022023-07-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), [키워드] disease severity immune response Infectious diseases microbial biomarkers Microbiome RNA viruses transcriptionally active microbes (TAMs). [DOI] 10.3389/fimmu.2022.1056036 PMC 바로가기 [Article Type] Review
Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19코로나19 중증도에 따라 항체 표적 SARS-CoV-2 에피토프 레퍼토리 달라Article Published on 2022-12-012022-09-11 Journal: Virulence [Category] COVID19(2023년), SARS, 진단, 치료법, [키워드] antibodies antibody Antigen association Asymptomatic asymptomatic individual asymptomatic infection Betacoronavirus betacoronavirus Community convalescent correlated COVID-19 COVID-19 severity develop diagnosed diagnostics disease severity domains Epitopes Evidence evidence of finding FIVE five groups HKU1 Hospitalization IgG IgGs Immunity immunogenic immunogenic peptide individual Infection less MERS-CoV nucleocapsid protein Nucleocapsid proteins OC43 participant pathogenic pathogenic mechanisms peptide peptide array peptides pilot study predicted Protein RBDs reaction Receptor binding domain Region repertoire SARS-CoV RBD SARS-CoV RBDs SARS-CoV-2 SARS-CoV-2 epitope SARS-CoV-2 epitopes seroconverted Seroprevalence seroprevalence. severity severity of COVID-19 symptomatic symptomatic COVID-19 symptomatic infection therapeutic therapeutic antibodies Vaccines Viral with COVID-19 without symptoms [DOI] 10.1080/21505594.2022.2073025 PMC 바로가기 [Article Type] Article
Clinical utility of circulating calprotectin to assist prediction and monitoring of COVID-19 severity: An Italian studyArticle Published on 2022-12-012022-11-15 Journal: Journal of medical virology [Category] 바이오마커, [키워드] Administered Admission assist Biomarker calprotectin Care chemiluminescent immunoassay circulating Circulating calprotectin clinical Cohort collected Concentration controls correlation COVID-19 COVID-19 pandemic COVID-19 patient COVID-19 patients disease severity evaluate healthy individual ICU intubation Italian study median Patient positive airway pressure Respiratory Support risk risk assessment. Sample serological serum severity of COVID-19 Severity of disease significantly higher tested utility were used [DOI] 10.1002/jmv.28056 PMC 바로가기
Risk factors for severe and critical Covid-19 in pregnant women in a single center in BrazilArticle Published on 2022-12-012023-07-06 Journal: The journal of maternal-fetal & neonatal medicine [Category] COVID19(2023년), [키워드] Brazil COVID-19 disease severity Pregnancy Risk factors. SARS-CoV-2 [DOI] 10.1080/14767058.2021.1880561 PMC 바로가기